Change Password!
Reset Password!
FDA approves the ‘first-ever’ oral therapy for eos...
Allergic rhinitis linked to bilateral eustachian t...
As per the outcomes of an observational cross-sectional study issued in the Journal of Marine Medical Society, the patients with allergic rh...
First Time for 10 Years AAAAI Changes Guidelines f...
Atopic dermatitis (AD) is the most common skin illness, with a prevalence of up to 20.1% in children and 2.1% to 4.9% in adults. AD is characteri...
Find out why Dexamethasone inserts are preferred o...
After comparing dexamethasone intracanalicular optic nerve insert (DEX) versus topical loteprednol (LOT) or olopatadine (OLO) in a recent real-wo...
Doxycycline ameliorates recurrent polyposis and in...
Compared to the standard management options, Doxycycline enhances the postoperative outcomes in patients battling refractory Chronic Rhinosinusit...
Sublingual immunotherapy displays noteworthy effic...
Often overlooked in treatment studies, epistaxis (commonly known as nosebleeds) is a common issue among allergic rhinitis (AR) patients. This ret...
Azathioprine offers hope for those battling pigmen...
In a recent study led by Surabhi Sinha and team, published in Clinical and Experimental Dermatology, a significant discovery has been made concer...
Abrocitinib 100mg predicts week 12 success in atop...
Research in 'Dermatology and Therapy' aimed to predict the early efficacy of Abrocitinib in atopic dermatitis, suggesting potential for e...
Xylometazoline hydrochloride for treating nasal co...
To evaluate the effects of Xylometazoline 0.1% spray (used thrice daily for a week) on quality of life (QoL) in people with congested nose (stuff...
Benralizumab: Promising results for eosinophilic a...
According to a recent post-hoc analysis of the ANANKE trial published in the Dovepress- Journal of Asthma and Allergy, the use of Benralizumab th...
